Healio

FDA approves Eylea HD for macular edema after retinal vein occlusion

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...
Ophthalmology Advisor

Posterior Staphyloma Morphology Affects Treatment Outcomes in High Myopic Macular Hole

The inverted ILM flap technique yields better macular hole closure than ILM peeling for some high myopic macular holes.
Managed Healthcare Executive

FDA approves Eylea HD for retinal vein occlusion

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Regeneron Gets FDA Approval for Eye Treatment Eylea

The approval is for Eylea to treat macular edema following retinal vein occlusion with up to every eight-week dosing after an initial dosing period. The FDA also approved a monthly dosing option for ...

EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

As Premature Births Rise In India, Why Retinopathy Of Prematurity Demands Attention; 6 Questions Every Parent Must Ask

A 2025 review shows India’s preterm birth rate at 13%. With over 23% of global preterm births, nearly 150,000 Indian infants ...